Suvretta Capital Management, LLC Abeona Therapeutics Inc. Transaction History
Suvretta Capital Management, LLC
- $2.54 Billion
- Q3 2024
A detailed history of Suvretta Capital Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 3,685,503 shares of ABEO stock, worth $21.6 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
3,685,503
Previous 3,685,503
-0.0%
Holding current value
$21.6 Million
Previous $15.6 Million
49.06%
% of portfolio
0.92%
Previous 0.65%
Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
61Shares Held
26.9MCall Options Held
614KPut Options Held
45K-
Nantahala Capital Management, LLC New Canaan, CT3.43MShares$20.1 Million1.29% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$19 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.3MShares$13.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$11.7 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$10.8 Million1.7% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $34.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...